Already forgotten? The company had repurchased 230 million common shares, reducing the number of shares outstanding by 43%. Mr. Gerard Dab, former CEO of Visual Healthcare Corp. and current CEO of VisualMED Clinical Solutions Corp., was instrumental in facilitating the transaction between the two parties.